Live Attenuated Respiratory Syncytial Virus (RSV) ∆NS2/∆1313/I1314L vaccine clinical trials

Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL)

This study is testing a new vaccine to protect babies and toddlers from a common winter bug called RSV. Researchers want to see how well it works, how safe it is, and if it helps stop serious lung infections caused by RSV.